IL-6 as a central driver of immune evasion in PDAC: from IDO-mediated tolerance to multi-pathway immunosuppression

• by Joyce Wang, Jolene Su Yi Tan, Vishal G. Shelat, Jackwee Lim

• July 7, 2026

Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports

• by Jing-Jing Li, Yu- Qian, Hui-Ting Xu, Yan-Li Nie

• July 7, 2026

This Week's CGT News: First Treg Therapy Approved

First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma

• July 7, 2026

• 6 min

Developing a predictive model for early urinary incontinence after laparoscopic radical prostatectomy: a retrospective cohort study

• by Yuan Tang, Tianlu Li, Xiaoxi Song, Linghui Qin

• July 7, 2026